Market Size of Canada Respiratory Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 8.73 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Canada Respiratory Devices Market Analysis
The Canadian respiratory devices market is expected to register a CAGR of 8.73 percent during the forecast period.
The SARS-CoV-2 virus responsible for the COVID-19 pandemic severely affected the respiratory system and had a significant impact on people with respiratory illnesses such as asthma or COPD in Canada; hence, the demand for both respiratory diagnostics and therapeutic devices increased significantly during the peak of the COVID-19 pandemic in Canada. For instance, an article published by the journal Physics of Fluids in January 2021 reported a surge in demand for oxygen concentrators and ventilators in hospitals across Canada. Thus, COVID-19 increased the demand for respiratory devices during the pandemic. However, in the current scenario, with the decrease in COVID-19 cases, the demand for respiratory devices in the country may get reduced compared to the beginning of the pandemic, but with the emergence of new SARS-CoV-2 strains and other respiratory disorders, the market is expected to witness significant growth over the forecast period.
The factors that are driving the studied market in the country are the increasing prevalence of respiratory disorders, such as COPD, TB, asthma, and sleep apnea, and technological advancements and their increasing applications in the homecare setting. For instance, in March 2022, the Government of Canada reported that in 2020, 4.7 active TB cases were reported per 100,000 people. The corresponding rate for females was 4.2 cases per 100,000 population, compared to 5.1 cases per 100,000 population for men. Similarly, an article published by Scientific Reports in August 2022 reported that in Canada, 3.8 million people lived with asthma in the year 2021. Thus, high cases of respiratory disorders are increasing the demand for respiratory devices, thereby driving the market.
Technological advancements and new product launches are also driving the market in the country. For instance, in November 2021, Ezzy Group Inc., Toronto, reported the successful development of the company's first-ever compostable surgical-grade face mask manufactured in Canada. These compostable masks are ASTM F-2100 certified and Health Canada approved. Similarly, in February 2022, Aptar Pharma launched HeroTracker Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device in North America. Thus, such product launches are providing better respiratory services to the people in the country, thereby driving the market.
Thus, due to the increasing prevalence of respiratory disorders, such as COPD, TB, asthma, and sleep apnea, and technological advancements and increasing applications in the homecare setting, the market is expected to witness significant growth over the forecast period. However, the high cost of respiratory devices may slow down the growth of the studied market.
Canada Respiratory Devices Industry Segmentation
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. They may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia.
Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnography, and Other Diagnostic and Monitoring Devices), Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, and Other Therapeutic Devices), and Disposables (Masks, Breathing Circuit, and Other Disposables). The report offers the value (in USD million) for the above segments.
By Diagnostic and Monitoring Devices | |
Spirometers | |
Sleep Test Devices | |
Peak Flow Meters | |
Pulse Oximeters | |
Capnographs | |
Other Diagnostic and Monitoring Devices |
By Therapeutic Device | |
CPAP Devices | |
BiPAP Devices | |
Humidifiers | |
Nebulizers | |
Oxygen Concentrators | |
Ventilators | |
Inhalers | |
Other Therapeutic Devices |
By Disposables | |
Masks | |
Breathing Circuit | |
Other Disposables |
Canada Respiratory Devices Market Size Summary
The Canadian respiratory devices market is poised for significant growth, driven by the increasing prevalence of respiratory disorders such as COPD, asthma, and sleep apnea, alongside technological advancements in the field. The demand for respiratory devices surged during the COVID-19 pandemic, particularly for oxygen concentrators and ventilators, but is expected to stabilize as pandemic-related demands decrease. However, the emergence of new SARS-CoV-2 strains and the ongoing prevalence of respiratory conditions continue to fuel market expansion. Technological innovations, such as smart inhalers and compostable masks, are enhancing respiratory care, while the growing application of these devices in homecare settings is further propelling market growth. Despite the high cost of respiratory devices posing a potential challenge, the market is expected to witness robust growth over the forecast period.
The market's growth is also supported by the increasing geriatric population and the rising incidence of respiratory disorders, which are driving the demand for inhalers and other respiratory devices. The prevalence of sleep apnea, particularly among children, adds to the market's expansion, as undiagnosed cases contribute to significant economic burdens. New product launches and strategic partnerships among key players, such as the introduction of innovative inhalers and remote monitoring solutions, are enhancing the market landscape. Companies like Koninklijke Philips N.V., Medtronic PLC, and GE Healthcare are leading the competitive market, with ongoing developments and collaborations aimed at improving respiratory health solutions in Canada.
Canada Respiratory Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
-
1.2.2 Technological Advancements and Increasing Applications in the Homecare Setting
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Devices
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Diagnostic and Monitoring Devices
-
2.1.1 Spirometers
-
2.1.2 Sleep Test Devices
-
2.1.3 Peak Flow Meters
-
2.1.4 Pulse Oximeters
-
2.1.5 Capnographs
-
2.1.6 Other Diagnostic and Monitoring Devices
-
-
2.2 By Therapeutic Device
-
2.2.1 CPAP Devices
-
2.2.2 BiPAP Devices
-
2.2.3 Humidifiers
-
2.2.4 Nebulizers
-
2.2.5 Oxygen Concentrators
-
2.2.6 Ventilators
-
2.2.7 Inhalers
-
2.2.8 Other Therapeutic Devices
-
-
2.3 By Disposables
-
2.3.1 Masks
-
2.3.2 Breathing Circuit
-
2.3.3 Other Disposables
-
-
Canada Respiratory Devices Market Size FAQs
What is the current Canada Respiratory Devices Market size?
The Canada Respiratory Devices Market is projected to register a CAGR of 8.73% during the forecast period (2024-2029)
Who are the key players in Canada Respiratory Devices Market?
Medtronic plc, General Electronic Company (GE Healthcare), Koninklijke Philips N.V., Gentige AB and Invacare Corporation are the major companies operating in the Canada Respiratory Devices Market.